Form 4: Century Therapeutics SVP Sells Shares for Tax Obligations

Douglas Carr, SVP Finance & Operations at Century Therapeutics, sold 263 shares to cover tax withholding from restricted stock unit vesting.

Summary

• Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), reported a sale of common stock.
• On September 8, 2025, Mr. Carr disposed of 263 shares of Century Therapeutics common stock.
• The shares were sold at a price of $0.5 per share.
• Following this transaction, Mr. Carr beneficially owns 405,423 shares of common stock.
• The sale was not discretionary and was executed automatically to cover tax withholding obligations associated with the vesting of restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale to cover tax obligations related to RSU vesting, which is a neutral event. It does not indicate a change in management's confidence or company performance.

Positives

• The transaction is a routine, non-discretionary sale to cover tax obligations, indicating a standard compensation event rather than a change in insider sentiment.

Negatives

• A minor reduction in insider ownership, though for a specific, non-discretionary reason.

Risks

• No specific risks beyond the routine nature of the transaction are mentioned in this filing.

Future Outlook

NA

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across all industries when executives receive equity compensation that vests and requires tax withholding. It does not provide specific industry-wide insights.

Stakeholder Impact

• Shareholders: A minor, non-discretionary reduction in insider ownership, which is a common occurrence with equity compensation. No significant impact on overall shareholder value or confidence is implied.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations associated with restricted stock unit vesting. Such transactions are common and do not typically signal a change in the company's fundamentals or management's outlook. Therefore, it provides no new information that would warrant a change from a 'hold' position based solely on this filing.

Keywords

Century Therapeutics, IPSC, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Douglas Carr, SVP Finance & Operations